No. | Author [reference number], year | Age | Sex | Viral infection | Underlying liver disease | Localization of tumor | Size (cm) of tumor before chemotherapy | Size (cm) of tumor after chemotherapy | Purpose of chemotherapy | Administration method/regimen/total courses | Surgical treatment | Adjuvant chemotherapy | Outcome |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Nakayama [6], 2012 | 78 | M | HCV | nd | S4/S5 | 8.0× | 7.0× | Downsizing chemotherapy | Hepatic arterial infusion/gemcitabine and cisplatin/3 courses | Central bisegmentectomy | None | Being followed up for 3 months |
2 | Kawashima et al. [13], 2012 | 57 | F | nd | nd | S1/S5/S6 | 7.0× | nd | Neoadjuvant chemotherapy | Intravenous/gemcitabine/ 2 courses | Right hepatectomy | Gemcitabine | Being followed up for 4 months |
3 | Current case | 59 | F | HBV | Chronic hepatitis | S4/S5/S8 | 6.5 | 3.8 | Downsizing chemotherapy | Intravenous/gemcitabine and cisplatin/11 courses | Extended left hepatectomy | S-1 | Being followed up for 14 months |